MYOGENIC AND NEUROGENIC MECHANISMS AND ARACHIDONATE METABOLITES IN BRONCHIAL MUSCLE RESPONSE TO ALLERGEN

Citation
Lj. Janssen et al., MYOGENIC AND NEUROGENIC MECHANISMS AND ARACHIDONATE METABOLITES IN BRONCHIAL MUSCLE RESPONSE TO ALLERGEN, American journal of physiology. Lung cellular and molecular physiology, 17(6), 1997, pp. 1118-1125
Citations number
24
ISSN journal
10400605
Volume
17
Issue
6
Year of publication
1997
Pages
1118 - 1125
Database
ISI
SICI code
1040-0605(1997)17:6<1118:MANMAA>2.0.ZU;2-T
Abstract
We investigated allergen-induced airway hyperresponsiveness (AH) in br onchial tissues obtained from dogs that inhaled Ascaris suum leading t o AH (RESP) in vivo or that exhibited no change (NON-RESP) as well as from dogs that inhaled saline (SHAM). RESP tissues were not hyperrespo nsive to KCl or to carbachol, whereas contractions to electrical field stimulation (EFS) were reduced. This reduction was reversed partially by indomethacin and completely by replacement of the bathing fluid. R adioimmunoassay revealed marked elevation of prostaglandin (PG) E-2 ge neration in RESP tissues compared with SHAM and NON-RESP tissues. EFS- evoked contractions were often followed by a slowly developing seconda ry contraction in RESP tissues but not in SHAM or NON-RESP tissues. Ho wever, indomethacin unmasked such secondary contractions in many SHAM and NON-RESP tissues and markedly enhanced those in RESP tissues, wher eas L-655,240 (thromboxane A(2)/PGD(2) receptor antagonist) abolished such contractions in all groups. We were unable to detect thromboxane using radioimmunoassay. We conclude that allergen-induced AH involves altered generation of cyclooxygenase metabolites of arachidonic acid ( particularly PGE(2)) as well as of a nonprostanoid inhibitory factor; as such, the responsiveness of the tissue in vitro is dependent on the relative levels of inhibitory and excitatory metabolites.